Related Experiment Video
Updated: Apr 16, 2026

Author Spotlight: Advancing Prostate Cancer Research Through Improved Tissue Sampling and Biobanking
Published on: November 17, 2023
Diagnostic concordance among pathologists interpreting breast biopsy specimens
Joann G Elmore1, Gary M Longton2, Patricia A Carney3
1Department of Medicine, University of Washington School of Medicine, Seattle.
Pathologist agreement on breast biopsy diagnoses was 75.3%, with lower accuracy for ductal carcinoma in situ (DCIS) and atypical hyperplasia. Diagnostic disagreement varied by breast density and pathologist practice characteristics.
Area of Science:
- Pathology
- Oncology
- Biopsy Analysis
Background:
- Accurate breast pathology diagnosis is crucial for guiding clinical treatment and management decisions.
- The reliability and accuracy of these diagnoses in routine practice are not fully understood.
Purpose of the Study:
- To quantify diagnostic disagreement among pathologists compared to a consensus panel reference diagnosis.
- To identify patient and pathologist characteristics associated with diagnostic discrepancies.
Main Methods:
- Pathologists interpreted a standardized set of 60 breast biopsy slides (240 cases).
- Cases included invasive breast cancer, ductal carcinoma in situ (DCIS), atypical hyperplasia, and benign conditions.
- Diagnoses were compared against a consensus panel's reference diagnosis.
Main Results:
- Overall concordance between individual pathologists and the consensus diagnosis was 75.3%.
- Concordance was highest for invasive carcinoma (96%) and lowest for atypia (48%).
- Diagnostic disagreement was higher for women with denser breasts and for pathologists with lower case volumes or in non-academic settings.
Conclusions:
- Pathologist agreement on breast biopsy interpretation shows significant variability, particularly for DCIS and atypia.
- Factors such as breast density and practice setting influence diagnostic accuracy.
- Further research is needed to correlate these findings with patient management outcomes.
More Related Videos
11:34Building Up a High-throughput Screening Platform to Assess the Heterogeneity of HER2 Gene Amplification in Breast Cancers
Published on: December 5, 2017
07:43Using 22C3 Anti-PD-L1 Antibody Concentrate on Biopsy and Cytology Samples from Non-small Cell Lung Cancer Patients
Published on: September 25, 2018